660 related articles for article (PubMed ID: 34080738)
1. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
Christensen EE; Jørgensen MJ; Nore KG; Dahl TB; Yang K; Ranheim T; Huse C; Lind A; Nur S; Stiksrud B; Jenum S; Tonby K; Holter JC; Holten AR; Halvorsen B; Dyrhol-Riise AM
J Intern Med; 2021 Sep; 290(3):677-692. PubMed ID: 34080738
[TBL] [Abstract][Full Text] [Related]
2. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.
Payen D; Cravat M; Maadadi H; Didelot C; Prosic L; Dupuis C; Losser MR; De Carvalho Bittencourt M
Front Immunol; 2020; 11():580250. PubMed ID: 33178207
[TBL] [Abstract][Full Text] [Related]
3. Persistent High Percentage of HLA-DR
Du J; Wei L; Li G; Hua M; Sun Y; Wang D; Han K; Yan Y; Song C; Song R; Zhang H; Han J; Liu J; Kong Y
Front Immunol; 2021; 12():735125. PubMed ID: 34567001
[TBL] [Abstract][Full Text] [Related]
4. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
Bieberich F; Vazquez-Lombardi R; Yermanos A; Ehling RA; Mason DM; Wagner B; Kapetanovic E; Di Roberto RB; Weber CR; Savic M; Rudolf F; Reddy ST
Front Immunol; 2021; 12():701085. PubMed ID: 34322127
[TBL] [Abstract][Full Text] [Related]
5. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
Front Immunol; 2020; 11():596553. PubMed ID: 33324414
[TBL] [Abstract][Full Text] [Related]
6. Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection.
Mahalingam SS; Jayaraman S; Arunkumar A; Dudley HM; Anthony DD; Shive CL; Jacobson JM; Pandiyan P
Front Immunol; 2023; 14():1231087. PubMed ID: 37799713
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
[TBL] [Abstract][Full Text] [Related]
8. Human CD8
Machicote A; Belén S; Baz P; Billordo LA; Fainboim L
Front Immunol; 2018; 9():2788. PubMed ID: 30555473
[TBL] [Abstract][Full Text] [Related]
9. Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.
Yu HB; Wang WJ; Tang S; Chen DX; Xu B
J Med Virol; 2021 Feb; 93(2):760-765. PubMed ID: 32644266
[TBL] [Abstract][Full Text] [Related]
10. Adaptive immunity to SARS-CoV-2 infection: A systematic review.
Silva MJA; Ribeiro LR; Lima KVB; Lima LNGC
Front Immunol; 2022; 13():1001198. PubMed ID: 36300105
[TBL] [Abstract][Full Text] [Related]
11. Frequencies of PD-1- and PD-L1- positive T CD3
Nowicka D; Grywalska E; Surdacka A; Grafka A; Roliński J
Microb Pathog; 2019 Jan; 126():85-91. PubMed ID: 30342909
[TBL] [Abstract][Full Text] [Related]
12. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
Albayrak N; Orte Cano C; Karimi S; Dogahe D; Van Praet A; Godefroid A; Del Marmol V; Grimaldi D; Bondue B; Van Vooren JP; Mascart F; Corbière V
Front Immunol; 2022; 13():769839. PubMed ID: 35422799
[TBL] [Abstract][Full Text] [Related]
13. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
Matic S; Popovic S; Djurdjevic P; Todorovic D; Djordjevic N; Mijailovic Z; Sazdanovic P; Milovanovic D; Ruzic Zecevic D; Petrovic M; Sazdanovic M; Zornic N; Vukicevic V; Petrovic I; Matic S; Karic Vukicevic M; Baskic D
PLoS One; 2020; 15(12):e0241097. PubMed ID: 33382687
[TBL] [Abstract][Full Text] [Related]
15. Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19.
Xie X; Cheng X; Wang G; Zhang B; Liu M; Chen L; Cheng H; Hao S; Zhou J; Zhu P; Cheng T
Sci China Life Sci; 2021 Oct; 64(10):1634-1644. PubMed ID: 33564978
[TBL] [Abstract][Full Text] [Related]
16. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
Front Immunol; 2021; 12():691725. PubMed ID: 34248984
[TBL] [Abstract][Full Text] [Related]
17. Detection of IFNγ-Secreting CD4
Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
[TBL] [Abstract][Full Text] [Related]
18. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.
Kos I; Balensiefer B; Lesan V; Kaddu-Mulindwa D; Thurner L; Christofyllakis K; Bittenbring JT; Ahlgrimm M; Seiffert M; Wagenpfeil S; Bewarder Y; Neumann F; Rixecker T; Smola S; Link A; Krawczyk M; Lammert F; Lepper PM; Bals R; Stilgenbauer S; Bewarder M
Eur J Immunol; 2021 Jun; 51(6):1449-1460. PubMed ID: 33788264
[TBL] [Abstract][Full Text] [Related]
19. PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response.
Loretelli C; Abdelsalam A; D'Addio F; Ben Nasr M; Assi E; Usuelli V; Maestroni A; Seelam AJ; Ippolito E; Di Maggio S; Loreggian L; Radovanovic D; Vanetti C; Yang J; El Essawy B; Rossi A; Pastore I; Montefusco L; Lunati ME; Bolla AM; Biasin M; Antinori S; Santus P; Riva A; Zuccotti GV; Galli M; Rusconi S; Fiorina P
JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34784300
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.
Li S; Wu B; Ling Y; Guo M; Qin B; Ren X; Wang C; Yang H; Chen L; Liao Y; Liu Y; Peng X; Xu C; Wang Z; Shen Y; Chen J; Liu L; Niu B; Zhu M; Liu L; Li F; Zhu T; Zhu Z; Zhou X; Lu H
Front Immunol; 2021; 12():625881. PubMed ID: 33717140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
